Cryoport, Inc. has seen its stock rise 82% year-to-date, driven by growth in cell and gene therapy commercialization and a robust pipeline. The company returned to adjusted EBITDA profitability in Q2 2026, supported by strong Life Science Services growth and $8 million in positive operating cash flow over the trailing twelve months. Management anticipates five new cell and gene therapy commercial approvals in 2026, with a 15% year-over-year increase in Phase 3 trials to 94. Risks include potential FDA rejection of therapies and biotech funding slowdowns, but Cryoport maintains a net cash position for reinvestment.
Cryoport's stock has surged 82% year-to-date amid a strong pipeline of cell and gene therapy approvals. For readers following the US health sector, here is Pluang's market snapshot as of Sep 25, 2026 14:41 WIB: out of 100 priced health-sector stocks, 39 rose and 56 fell today. Notable movers include HRTX at USD 0.30 with a 1-day change of +3.45% and Pluang order activity showing 82% Sell / 18% Buy, TMDX at USD 84.00 down 3.45% with 0% Sell / 100% Buy, and HCA at USD 422.89 down 3.11% with 0% Sell / 100% Buy.
U.S.-listed spot Bitcoin ETFs have reversed their fortunes in 2026, moving from a net outflow of $5.8 billion in July to nearly $800 million in net inflows by September. This turnaround aligns with Bitcoin's price recovery to about $85,000 from under...
Stellar Lumens (XLM) rose 9.66% to $0.2212 on September 25, 2026, driven by a sharp increase in tokenized real-world assets (RWA) on its blockchain, which grew from $869 million to nearly $4 billion within eight months. This growth boosts network act...
XRPL developers have proposed a new Permissioned Automated Market Maker (AMM) concept to extend existing credential and permissioned domain controls to native liquidity pools. This would allow only wallets with approved credentials to provide liquidi...
Chainlink (LINK), the 14th-largest cryptocurrency by market cap, surged 3.09% in one hour to $13.93, extending its 24-hour gain to 13.18%. The token's market capitalization reached about $10.23 billion. During this period, short liquidations totaled ...
The share of Ether (ETH) held on tracked exchanges has fallen to a record low of 3.49%, reducing the amount of ETH immediately available for trading or selling. Since June 1, this share has declined by 1.16%, reflecting that more ETH is held off exch...
